Progress in Research of KV1.1 and KV1.3 Channels as Therapeutic Targets
- PMID: 26975504
- DOI: 10.2174/1568026616666160315142920
Progress in Research of KV1.1 and KV1.3 Channels as Therapeutic Targets
Abstract
Voltage-gated potassium channels (KV) mainly response in action potential repolarization in excitable cells and also participate in regulating resting potentials in non-excitable cells, involved in diverse physiological processes. This review focuses on potential drug developments targeting the KV1.1 and KV1.3 channels. KV1.1 mainly existing in the nervous system plays key roles in controlling neuronal excitability; while the distribution of KV1.3 in different types of cells contributes to a variety of cellular processes. This article seeks to review the distributions of two channels, their roles in diseases, phenotypes of knockout mice, human channelopathies and selective modulators.
Similar articles
-
Roles of specific Kv channel types in repolarization of the action potential in genetically identified subclasses of pyramidal neurons in mouse neocortex.J Neurophysiol. 2016 May 1;115(5):2317-29. doi: 10.1152/jn.01028.2015. Epub 2016 Feb 10. J Neurophysiol. 2016. PMID: 26864770 Free PMC article.
-
Differential contributions of voltage-gated potassium channel subunits in enhancing temporal coding in the bushy cells of the ventral cochlear nucleus.J Neurophysiol. 2021 May 1;125(5):1954-1972. doi: 10.1152/jn.00435.2020. Epub 2021 Apr 14. J Neurophysiol. 2021. PMID: 33852808
-
Voltage-gated K+ channels in rat small cerebral arteries: molecular identity of the functional channels.J Physiol. 2003 Sep 15;551(Pt 3):751-63. doi: 10.1113/jphysiol.2003.040014. Epub 2003 Jun 18. J Physiol. 2003. PMID: 12815189 Free PMC article.
-
The impact of ancillary subunits on small-molecule interactions with voltage-gated potassium channels.Curr Pharm Des. 2006;12(18):2285-302. doi: 10.2174/138161206777585175. Curr Pharm Des. 2006. PMID: 16787255 Review.
-
Molecular mechanisms of cardiac voltage-gated potassium channelopathies.Curr Pharm Des. 2006;12(28):3631-44. doi: 10.2174/138161206778522065. Curr Pharm Des. 2006. PMID: 17073664 Review.
Cited by
-
Inhibitory Effects of 2-Aminoethoxydiphenyl Borate (2-APB) on Three KV1 Channel Currents.Molecules. 2023 Jan 15;28(2):871. doi: 10.3390/molecules28020871. Molecules. 2023. PMID: 36677928 Free PMC article.
-
N-Terminal Tagging with GFP Enhances Selectivity of Agitoxin 2 to Kv1.3-Channel Binding Site.Toxins (Basel). 2020 Dec 16;12(12):802. doi: 10.3390/toxins12120802. Toxins (Basel). 2020. PMID: 33339256 Free PMC article.
-
Effects of Kv1.3 knockout on pyramidal neuron excitability and synaptic plasticity in piriform cortex of mice.Acta Pharmacol Sin. 2024 Oct;45(10):2045-2060. doi: 10.1038/s41401-024-01275-y. Epub 2024 Jun 11. Acta Pharmacol Sin. 2024. PMID: 38862816
-
New High-Affinity Peptide Ligands for Kv1.2 Channel: Selective Blockers and Fluorescent Probes.Cells. 2024 Dec 18;13(24):2096. doi: 10.3390/cells13242096. Cells. 2024. PMID: 39768187 Free PMC article.
-
Treatment of Radiation-Induced Brain Necrosis.Oxid Med Cell Longev. 2021 Dec 24;2021:4793517. doi: 10.1155/2021/4793517. eCollection 2021. Oxid Med Cell Longev. 2021. PMID: 34976300 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources